LDS/Medical Tests/Avantect Pancreatic Cancer Test

Avantect Pancreatic Cancer Test

Pancreatic cancer is the third leading cause of cancer-related deaths worldwide, with high mortality due to late-stage diagnosis and the lack of specific blood-based biomarkers. The Avantect Pancreatic Cancer Test is a liquid biopsy assay that detects circulating tumor DNA (ctDNA) in blood samples, focusing on epigenetic alterations. This test specifically identifies the presence of 5-hydroxymethylcytosine (5hmC) modifications in methylated cytosine bases, which are associated with pancreatic tumorigenesis. By leveraging next-generation sequencing (NGS) technology, the Avantect test provides a non-invasive means of detecting pancreatic cancer at varying stages with high sensitivity and specificity.

The Avantect test has been validated in patients at a high risk for developing pancreatic cancer, including those aged 50 and older who are newly diagnosed with type 2 diabetes and those with a genetic predisposition and/or family history of pancreatic cancer. The test’s performance has an overall sensitivity of 66.7% and specificity of 96.9%.

  • Aids in the early detection and diagnosis of pancreatic cancer
  • Supports risk assessment for individuals predisposed to pancreatic malignancies
  • Complements existing diagnostic tools, such as imaging and conventional tumor markers (e.g., CA19-9)

Positive result
Detection of abnormal 5hmC epigenetic signals suggests the presence of pancreatic malignancy.

Negative result
No detectable abnormal epigenetic signals, indicating a lower likelihood of pancreatic cancer. However, absence of detection does not completely rule out malignancy.

Not detected

Next-generation sequencing (NGS) with 5-hydroxymethylcytosine enrichment.

Whole blood (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: Unacceptable
Amylase, Lipase, CA19-9, PancreaSeq genetic panel, Biopsy, pancreas.
1-3 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login